R, S., M, I., WR, W., CA, B., JE, H., P, H., . . . JRS, D. (2025). Sustained growth-promoting effects of vosoritide in children with achondroplasia from an ongoing phase 3 extension study. Med (New York, N.Y.), 6(5), 100566. https://doi.org/10.1016/j.medj.2024.11.019
Chicago Style (17th ed.) CitationR, Savarirayan, et al. "Sustained Growth-promoting Effects of Vosoritide in Children with Achondroplasia from an Ongoing Phase 3 Extension Study." Med (New York, N.Y.) 6, no. 5 (2025): 100566. https://doi.org/10.1016/j.medj.2024.11.019.
MLA (9th ed.) CitationR, Savarirayan, et al. "Sustained Growth-promoting Effects of Vosoritide in Children with Achondroplasia from an Ongoing Phase 3 Extension Study." Med (New York, N.Y.), vol. 6, no. 5, 2025, p. 100566, https://doi.org/10.1016/j.medj.2024.11.019.